Penn doubles the percentage of Black participants in cancer clinical trials
"An important goal of the Abramson Cancer Center is to serve and engage our community --and that includes improving access to clinical trials for all patients," said senior author Robert H. Vonderheide, MD, DPhil, director of the ACC and vice president for Cancer Programs in the University of Pennsylvania Health System. "Aligning the number of Black patients with cancer we care for with the number enrolled in our trials is how we can help bring more equitable care to the community, close gaps in disparities, and sustain trust. There's more work to be done to improve access and inclusion of m...